Project Grant HT94252410670
Award Date
6/1/24
Completion Date
5/31/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Albuquerque, NM 87108, USA
Similar Awards
The Lovelace Biomedical Research Institute will receive $734,613 through a Cooperative Agreement award from the Department of the Army Medical Command to quantify the sensitivity and specificity of point-of-care biomarkers in a large-animal model of mild traumatic brain injury. The funding is provided under the Military Medical Research and Development program (CFDA 12.420) to support basic, applied, and advanced biomedical research that transforms healthcare for service members and the public...
The Defense Health Agency awarded a $2,371,837 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Medstar Health Research Institute Inc. to conduct a pilot multicenter study on resuscitation with enteral fluids. The grant will fund a 3-year research project starting July 2024 that focuses on transforming healthcare for military service members and the broader public. The grant includes a sub-award to Louisiana State University Health Sciences Center New...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The federal Project Grant award of $837,500.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research on "OXYGEN CONSERVING REFLEX: A NOVEL MULTIMECHANISTIC THERAPEUTIC INTERVENTION FOR TBI." The research will investigate an innovative approach to address traumatic brain injury (TBI) by examining a novel oxygen conserving reflex. The award will support this...
The Department of the Army Medical Command awarded a $1,999,583 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to IRR Inc. in Santa Barbara, CA. The grant will fund an early-stage proof-of-concept study of a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The 2-year project, running from July 1, 2025 to June 30, 2027, aims to advance medical solutions for the battlefield and transform healthcare for...
The Defense Health Agency awarded a $749,905 Project Grant to The Roskamp Institute Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to investigate microglial NOX2/NLRP3 inflammasome activation and its role in driving tau pathology and cognitive impairments in chronic traumatic brain injury. Specifically, the Roskamp Institute will conduct basic, applied, and advanced biomedical...
The U.S. Defense Health Agency has awarded a $1,395,898 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Medicortex Finland LTD for the project titled "POINT-OF-INJURY DIAGNOSIS OF TRAUMATIC BRAIN INJURY USING SALIVA". The 2-year grant, effective from June 15, 2024 to June 14, 2026, will fund research to develop a point-of-injury diagnostic tool for traumatic brain injury using saliva samples. This aligns with the program's objective of...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...